Skip to main content
. 2020 Dec 7;11:606497. doi: 10.3389/fphar.2020.606497

FIGURE 1.

FIGURE 1

(A) Total back pain, (B) nocturnal back pain, (C) swollen joint count, (D) MASES, (E) PaGA, (F) PhGA, and (G) BASDAI values at each time point during the 24-week treatment period in patients treated with HS016 or adalimumab. *p < 0.05, compared with baseline in the HS016 group; # p < 0.05, compared with baseline in the adalimumab group. BASDAI, Bath ankylosing spondylitis disease activity index; MASES, Maastricht ankylosing spondylitis enthesitis score; PaGA, Patient global assessment; PhGA, Physician global assessment; SJC, swollen joint count.